Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734955 · ClinicalTrials.gov registry record · NA
An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 485
- Enrollment target
NCT00734955: Completed NA study, sponsored by Duke University.
NCT00734955 is a NA study that has completed, run by Duke University. The registered enrollment target is 485 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00734955, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 485 participants
- Enrollment target
Study Summary
Our objective is to develop a novel optical assay system for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens. Our group has previously shown that optical techniques can effectively discriminate between malignant and non-malignant breast tissues. We have also shown that data collection and processing from a single point on the tissue specimen requires less than 5 seconds. In addition, the technique is easily adaptable to provide sensing depths that are required for breast margin assessment. The goal of the work proposed in this protocol is to test the sensitivity and specificity of an optical assay system developed by our group, for intra operative assessment of breast tumor margins.
Primary Outcome
The primary outcome measure of this study is to identify the optical signatures of normal and cancerous tissue.
Interventions
- DEVICE 49-channel optical spectrometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2006-05 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT00734955 record still lists
NCT00734955 is an interventional study that assigns participants to a tested intervention. The registered 485 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which 49-channel optical spectrometer is the first listed.
NCT00734955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00734955 about?
NCT00734955 is a clinical study titled "An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients". Our objective is to develop a novel optical assay system for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens. Our group has previously shown that optical techniques can effectively discriminate between malignant and non-malignant breast tissues. We have also...
What is the current status of trial NCT00734955?
This trial is currently completed. It is a NA study. The enrollment target is 485 participants. The study started on 2006-05. Estimated completion is 2017-07.
What interventions are being tested in trial NCT00734955?
The interventions under investigation include: 49-channel optical spectrometer (DEVICE).
Who is sponsoring clinical trial NCT00734955?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00734955's enrollment target sits among peer trials
485 216th of 2000 higher than 1,785 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
- NCT07097142 · 486 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia